...

Pieris Pharmaceuticals GmbH

Visitar página Web

Sobre el empleador

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.

Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest.

Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Roche, Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma.

Pieris, founded in 2001, was funded by premier biotechnology-focused venture capital firms including OrbiMed Advisors as its lead investor as well as Forbion Capital, Gilde Healthcare Partners, Novo Nordisk Ventures, Global Life Science Ventures, BayTech Venture Capital, Bio-M, TCB, KfW and BayernKapital.

Pieris has become a publicly traded company on December 18, 2014 (NASDAQ:PIRS).

Ubicación de la empresa

Descubre empleadores similares

...
University of Luxembourg Luxemburgo 103 posiciones abiertas
...
KU Leuven Lovaina, Bélgica 91 posiciones abiertas
...
Ghent University Gante, Bélgica 69 posiciones abiertas
...
University of Twente Enschede, Holanda 61 posiciones abiertas
...
ETH Zürich Zúrich, Suiza 61 posiciones abiertas
Más empleadores

Esto puede ser de tu interés

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 minutos de lectura
...
The genetic detectives discovering who we really are University of Turku 5 minutos de lectura
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 minutos de lectura
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 minutos de lectura
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 minutos de lectura
Más historias